Xcout Intel
Domain Therapeutics competitors & alternatives
The 12 closest competitors and alternatives to Domain Therapeutics among biotech companies — ranked by similarity to what Domain Therapeutics actually does, not by market-cap band.
Subscribe to see Domain Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Domain Therapeutics
Domain Therapeutics is a French biopharmaceutical company focused on discovering and developing drugs that target G-protein-coupled receptors (GPCRs), including applications in oncology and immuno-oncology. It serves pharmaceutical and biotechnology partners through proprietary drug-discovery programs, technology platforms, and licensing or collaboration agreements.
Domain Therapeutics at a glance
Domain Therapeutics is a biotech company headquartered in France. Xcout tracks 12 named people at Domain Therapeutics, including Sean A. MacDonald (Chief Executive Officer).
Domain Therapeutics leadership
- Sean A. MacDonaldChief Executive Officer
- Stanislas-Léonard MalmezatChief Financial Officer
- Jean-Marie CuillerotChief Medical Officer
- Stephan SchannChief Scientific Officer
- Aurélie MaisnerDirector of Human Resources
- Marjorie SidhoumVice-President Business Development & Corporate Communication
6 more named people on record for Domain Therapeutics, with roles, board committees and tenure — see the full roster →
Top 12 Domain Therapeutics competitors
Ranked by semantic similarity — how close each company is to Domain Therapeutics by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotechnology
Dome Therapeutics is a preclinical biotechnology company developing a nanomedicine designed to target brain cancer stem cells that survive standard glioblastoma treatments and drive tumor recurrence. Using a proprietary nanoparticle delivery platform, the company aims to cross the blood-brain barrier to deliver therapeutic payloads directly to these treatment-resistant cells.
Biotechnology
Mebias Discovery, Inc. is a biotechnology company headquartered in Philadelphia, Pennsylvania, focused on drug discovery targeting G-protein coupled receptors.
Similar biotech company
Oncodesign Precision Medicine is a biopharmaceutical company that develops innovative therapeutic and diagnostic solutions targeting treatment resistance, metastasis, and diseases such as oncology, inflammatory bowel disease, and Parkinson's disease. Utilizing proprietary technologies like OncoSNIPER, Nanocyclix, and PROMETHE, the company advances first-in-class and best-in-class precision medicine programs to serve patients, clinicians, and pharmaceutical partners.
Similar biotech company
Tectonic Therapeutic, Inc. operates as a clinical-stage biotechnology firm dedicated to the identification and progression of biologic therapies, primarily therapeutic proteins and antibodies, that regulate the function of G-protein coupled receptors (GPCRs). The company leverages its proprietary GEODe technology platform to facilitate the discovery and development of these GPCR-targeted medicines. Its robust pipeline includes an RXFP1 agonist, currently undergoing Phase 1a and 1b clinical trials for the treatment of heart failure with preserved ejection fraction. Additional programs encompass a GPCR antagonist addressing hereditary hemorrhagic telangiectasia, a bi-functional GPCR modulator aimed at fibrosis, and various other GPCR modulators. Tectonic Therapeutic, Inc. is situated in Watertown, Massachusetts.
Similar biotech company
Evotec is a life science company that provides drug discovery and preclinical development services, working across modalities from small molecules to biotherapeutics. Through its subsidiary Just - Evotec Biologics, the company focuses on the design, development, and manufacturing of biologics to make therapies more accessible and affordable for partners in the pharmaceutical and biotechnology industries.
Biotechnology
Defence Therapeutics is a publicly traded Canadian biotechnology company headquartered in Montreal, Quebec. It is a precision intracellular drug-delivery company focused on unlocking the full potential of cancer biologics.
Biotechnology
Meddenovo Drug Design is a Lyon, France-based biotechnology company operating at the intersection of AI and life sciences to build advanced computational technologies for peptide drug discovery.
Biotechnology
Septerna, Inc., a clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products for the treatment of endocrinology, immunology and inflammation, and metabolic diseases. It develops PTH1R Program, oral small molecule Parathyroid Hormone 1 Receptor agonists for the treatment of hypoparathyroidism; SEP-631, an oral small molecule MRGPRX2 negative allosteric modulator (NAM) for chronic spontaneous urticaria and other mast cell diseases; and TSHR Program, an oral small molecule TSHR NAM for graves’ disease and thyroid eye disease. In addition, it focuses on other therapeutic areas, including neurology, women’s health, cardiovascular disease, and respiratory disease. It has global collaboration and license agreement with Novo Nordisk to discover, develop and commercialize multiple potential oral small molecule therapies for metabolic-related diseases based on certain specified molecular targets. The company was formerly known as GPCR NewCo, Inc. and changed its name to Septerna Inc. in June 2021. Septerna, Inc. was incorporated in 2019 and is headquartered in South San Francisco, California.
Similar biotech company
Valerio Therapeutics is a biotechnology company that develops precision-guided therapeutics for complex and underserved diseases. It utilizes a proprietary V-Body conjugate platform, based on synthetic single-domain antibody libraries, to enable targeted drug delivery and deep tissue penetration.
Similar biotech company
Dualitas Therapeutics is a privately held biotechnology research company headquartered in South San Francisco, California, that utilizes its DualScreen Bispecific Discovery Engine for proximity engagers.
Similar biotech company
Qubit Pharmaceuticals is a privately held company headquartered in Paris, France, that brings precision to drug discovery and design by utilizing cutting-edge quantum physics-based science to develop life-changing treatments.
Biotechnology
Alixia, Inc. is a biotechnology company that develops therapeutics targeting tumor ecosystems to address cancer drug resistance and complex, chronic diseases. The company utilizes a research platform integrating biology, biophysics, computational chemistry, and clinical input to discover lead compounds that disrupt metabolic and inflammatory triggers within the tumor microenvironment.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Domain Therapeutics and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Domain Therapeuticsand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →